Evaluating Large Language Models as Tools to Navigate Researchers in Rapidly Evolving Research Landscapes: A Case Study in Cancer Drug Response Prediction
Large Language Models (LLMs) have emerged as promising tools for assisting researchers in automating and accelerating the synthesis of literature reviews. However, their reliability is a significant concern due to issues like factual inaccuracies and hallucinations. The key question is whether LLMs can reliably provide comprehensive, up-to-date overviews and analyses. This study evaluates the performance of three leading LLMs (OpenAI’s ChatGPT, Google’s Gemini, and DeepSeek) on the complex task of generating a comprehensive survey paper on deep learning for cancer Drug Response Prediction (DRP). By testing both standard and Deep Research (DR) / Deep Think (DT) modes of LLMs with prompts of varying detail, this paper assesses key academic dimensions, including reference management, content quality, and analytical depth. Key findings reveal that while DR modes of LLMs significantly improve reliability by eliminating hallucinations, performance variations exist across models and prompts. A trade-off between reference quantity and integration quality was observed, and even the best-performing models lacked the analytical depth of human experts, often requiring extensive human supervision. The study concludes that LLMs currently serve as powerful assistive tools but still cannot replace the critical validation and synthesis provided by human researchers. Choosing the best LLM to use depends on the task in hand, while several strategies can be implemented to improve the produced output.
This study compares the performance of three LLMs in extracting, analyzing, and synthesizing regulatory and clinical information from FDA drug reviews, guidance for the industry, and drug labels as accessed through their standard user interfaces, using antibiotics approved for complicated urinary tract infections betwe...
Khulud Bukhari, R. Rodriguez-Monguio, B. Lopez-Bermudez et al.· Discover Artificial Intellig...· 0 citations
Background: Rare diseases affect an estimated 300 million people worldwide, yet the research needed to guide diagnosis and treatment is often fragmented across multiple unstructured literature sources. Natural history studies (NHS) are a key source of this evidence, but manually extracting structured information from N...
INTRODUCTION
The demand for inventive approaches to drug discovery has increased due to the rising costs, time, and failure rates in pharmaceutical research. Large Language Models (LLMs), with their sophisticated natural language processing and generative capabilities, have become potent instruments that have the poten...
Pranay Wal, M. Shukla, Kritika Sachan et al.· Current Computer - Aided Dru...· 0 citations
Synergizing a curated domain-specific knowledge base with LLMs via a RAG architecture is an effective strategy for accurately identifying ADEs in unstructured Chinese clinical notes, providing a foundational open-source benchmark and a robust technical framework to advance pharmacovigilance, drug safety research, and c...
Junlong Ma, Xue-Hong Wu, Zeying Feng et al.· Journal of Medical Internet...· 0 citations
Abstract Background Large language model (LLM) agents capable of generating and executing statistical code from natural language may broaden access to clinical data analysis, yet which pipeline stages they perform reliably and which require expert oversight remain poorly defined. Objective This study aimed to evaluate...
Yi-Lan Wu, D. J. Fu, Yu-Kun Zhou et al.· Journal of Medical Internet...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.